These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2290625)

  • 21. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
    Meller E; Bordi F; Bohmaker K
    Life Sci; 1989; 44(15):1019-26. PubMed ID: 2564615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for dopaminergic innervation on kitten retinal ganglion cells.
    Ikeda H; Robbins J; Wakakuwa K
    Brain Res; 1987 Sep; 432(1):83-9. PubMed ID: 3308006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for central selective dopamine receptor stimulation in the mediation of nomifensine-induced hyperalgesia and the effects of opiate antagonists.
    Gonzalez JP; Sewell RD; Spencer PS
    Neuropharmacology; 1981 Nov; 20(11):1039-45. PubMed ID: 6275288
    [No Abstract]   [Full Text] [Related]  

  • 24. Is lower leg proprioception essential for triggering human automatic postural responses?
    Bloem BR; Allum JH; Carpenter MG; Honegger F
    Exp Brain Res; 2000 Feb; 130(3):375-91. PubMed ID: 10706436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of dopamine receptors in the renal vasculature by isomers of flupenthixol and sulpiride.
    Schmidt M; Imbs JL; Giesen EM; Schwartz J
    J Cardiovasc Pharmacol; 1983; 5(1):86-9. PubMed ID: 6186865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
    Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine.
    Israel JM; Jaquet P; Vincent JD
    Endocrinology; 1985 Oct; 117(4):1448-55. PubMed ID: 4029087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interlimb coordination of leg-muscle activation during perturbation of stance in humans.
    Dietz V; Horstmann GA; Berger W
    J Neurophysiol; 1989 Sep; 62(3):680-93. PubMed ID: 2769353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain.
    Merchant KM; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1989 Oct; 500(1-2):21-9. PubMed ID: 2532557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydroergotoxine decreases blood pressure in spontaneously hypertensive rats by interacting with peripheral dopamine receptors.
    Memo M; Sagheddu G; Carruba MO; Spano P
    Life Sci; 1985 Apr; 36(16):1515-22. PubMed ID: 3982223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dopamine on postural control in parkinsonian subjects: scaling, set, and tone.
    Horak FB; Frank J; Nutt J
    J Neurophysiol; 1996 Jun; 75(6):2380-96. PubMed ID: 8793751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of proprioceptive mechanisms in the regulation of stance.
    Dietz V; Horstmann GA; Berger W
    Prog Brain Res; 1989; 80():419-23; discussion 395-7. PubMed ID: 2634280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compensation of human stance perturbations: selection of the appropriate electromyographic pattern.
    Dietz V; Trippel M; Discher M; Horstmann GA
    Neurosci Lett; 1991 May; 126(1):71-4. PubMed ID: 1866087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The action of dopamine receptor antagonists on the secretory response of the cockroach salivary gland in vitro.
    Evans AM; Green KL
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1990; 97(2):283-6. PubMed ID: 1982871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
    Reuss B; Unsicker K
    Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
    Kobayashi T; Shimizu H; Toru M
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):331-4. PubMed ID: 1979198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP.
    Altar CA; Boyar WC; Kim HS
    Eur J Pharmacol; 1990 May; 181(1-2):17-21. PubMed ID: 1974856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central acute D2 stimulation worsens bladder function in patients with mild Parkinson's disease.
    Brusa L; Petta F; Pisani A; Miano R; Stanzione P; Moschella V; Galati S; Finazzi Agrò E
    J Urol; 2006 Jan; 175(1):202-6; discussion 206-7. PubMed ID: 16406911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptics with differential affinities at dopamine D2 receptors and sigma receptors affect differently the N-methyl-D-aspartate-induced increase in intracellular calcium concentration: involvement of protein kinase.
    Hayashi T; Su TP; Kagaya A; Nishida A; Shimizu M; Yamawaki S
    Synapse; 1999 Jan; 31(1):20-8. PubMed ID: 10025680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.